Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Abstract:
- N-ribosylation and N-mannosylation compounds have a great role in compounds activity as anticancer.
- The reaction of 2-thioxo-4-thiazolidinone (rhodanine) derivatives, as aglycon part, was done with ribofuranose and mannopyranose sugars (glycone part) followed by deacetylation without cleavage of the rhodanine under acidic medium.
- Conformational analysis has been studied using NMR methods (2D, DQF-COSY, HMQC and HMBC).
- All final the new deprotected nucleosides were screened against leukemia 1210, and were found to be considerably less potent (Ic50% 1.4-10.6 ?M) than doxorubicin (Ic50% 0.02 ?M).
- The compounds contain ribose moiety have better activity than those with mannose sugar.
- DFT calculations with B3LYP/6-31+G (d) level were used to analyze the electronic and geometric characteristics deduced from the stable structure of the compounds.
- The principal quantum chemical descriptors showed a good correlation with the experimental observations.
- Rapid Overlay Comparison Similarity (ROCS) study was operated to explain the compounds similarity and to figure out the most important pharmacophoric features.